Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Stock Exchange of Hong Kong  >  CSPC Pharmaceutical Group Limited    1093   HK1093012172

CSPC PHARMACEUTICAL GROUP LIMITED

(1093)
  Report  
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

CSPC Pharmaceutical Group Ltd : quaterly earnings release

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/22/2018 | 09:15am EDT

The company will report its earnings for Q1 2018 on 05/25/2018. Generally, the company reports earnings worse than estimates. In recent months, the 22 analysts from Thomson Reuters consensus have revised their EPS estimates upward.

Stocks mentioned in the article
ChangeLast1st jan.
CSPC PHARMACEUTICAL GROUP LIMITED -0.23% 17.4 End-of-day quote.54.53%
THOMSON REUTERS CORPORATION 0.06% 87.34 Delayed Quote.32.19%

© MarketScreener.com 2018
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CSPC PHARMACEUTICAL GROUP
10/22CSPC PHARMACEUTICAL : Voluntary announcement - anti-tumor nanodrug "epirubicin h..
PU
10/21CSPC PHARMACEUTICAL : Voluntary announcement - investigational new drug almb-016..
PU
10/18CSPC PHARMACEUTICAL : Voluntary announcement - first-in-class product candidate ..
PU
10/14CSPC PHARMACEUTICAL : Inside information - announcement on the indicative result..
PU
10/08China, Hong Kong stocks rise on stimulus hopes; trade talks in focus
RE
09/26CSPC PHARMACEUTICAL : Voluntary announcement - drug registration approval of the..
PU
09/26CSPC PHARMACEUTICAL : Voluntary announcement - drug registration approval of the..
PU
09/23CSPC PHARMACEUTICAL : First-in-class product candidate almb-0168 was granted orp..
PU
09/12NOTIFICATION LETTER AND REQUEST FORM : Notice of publication of 2019 interim rep..
PU
09/10ASIA MARKETS: Asian Markets Gain Ahead Of ECB Meeting
DJ
More news
Financials (HKD)
Sales 2019 25 343 M
EBIT 2019 5 368 M
Net income 2019 4 381 M
Finance 2019 6 627 M
Yield 2019 1,39%
P/E ratio 2019 24,8x
P/E ratio 2020 20,4x
EV / Sales2019 3,93x
EV / Sales2020 3,20x
Capitalization 106 B
Chart CSPC PHARMACEUTICAL GROUP LIMITED
Duration : Period :
CSPC Pharmaceutical Group Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CSPC PHARMACEUTICAL GROUP
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 30
Average target price 18,79  HKD
Last Close Price 17,40  HKD
Spread / Highest target 55,6%
Spread / Average Target 8,01%
Spread / Lowest Target -19,5%
EPS Revisions
Managers
NameTitle
Dong Chen Cai Chairman & Co-Chief Executive Officer
Cuilong Zhang Vice Chairman & Co-Chief Executive Officer
Wei Dong Pan Executive Director
Ka Sze Lee Secretary & Non-Executive Director
Huai Yu Wang Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
CSPC PHARMACEUTICAL GROUP LIMITED54.53%13 836
JOHNSON & JOHNSON0.12%340 980
ROCHE HOLDING AG18.71%249 928
MERCK AND COMPANY6.40%208 158
PFIZER-16.54%201 496
NOVARTIS15.69%199 249